Response to letter to the editor on "anti-psoriatic drug monomethylfumarate increases nuclear factor erythroid 2-related factor 2 levels and induces aquaporin-3 mrna and protein expression"

Wendy B Bollag, Inas Helwa, Vivek Choudhary, Xunsheng Chen, Ismail Kaddour-Djebbar

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)449-451
Number of pages3
JournalJournal of Pharmacology and Experimental Therapeutics
Volume364
Issue number3
DOIs
StatePublished - Mar 1 2018

Fingerprint

Aquaporin 3
Pharmaceutical Preparations
citraconic acid

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

@article{b036256270ca4111ba17cda220a7960f,
title = "Response to letter to the editor on {"}anti-psoriatic drug monomethylfumarate increases nuclear factor erythroid 2-related factor 2 levels and induces aquaporin-3 mrna and protein expression{"}",
author = "Bollag, {Wendy B} and Inas Helwa and Vivek Choudhary and Xunsheng Chen and Ismail Kaddour-Djebbar",
year = "2018",
month = "3",
day = "1",
doi = "10.1124/jpet.117.246595",
language = "English (US)",
volume = "364",
pages = "449--451",
journal = "The Journal of pharmacology and experimental therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Response to letter to the editor on "anti-psoriatic drug monomethylfumarate increases nuclear factor erythroid 2-related factor 2 levels and induces aquaporin-3 mrna and protein expression"

AU - Bollag, Wendy B

AU - Helwa, Inas

AU - Choudhary, Vivek

AU - Chen, Xunsheng

AU - Kaddour-Djebbar, Ismail

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85041683696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041683696&partnerID=8YFLogxK

U2 - 10.1124/jpet.117.246595

DO - 10.1124/jpet.117.246595

M3 - Letter

VL - 364

SP - 449

EP - 451

JO - The Journal of pharmacology and experimental therapeutics

JF - The Journal of pharmacology and experimental therapeutics

SN - 0022-3565

IS - 3

ER -